WO2005002591A8 - Treatment psoriasis, impetigo, tinea by lipositol, cephalin and lecithin - Google Patents
Treatment psoriasis, impetigo, tinea by lipositol, cephalin and lecithinInfo
- Publication number
- WO2005002591A8 WO2005002591A8 PCT/EG2004/000008 EG2004000008W WO2005002591A8 WO 2005002591 A8 WO2005002591 A8 WO 2005002591A8 EG 2004000008 W EG2004000008 W EG 2004000008W WO 2005002591 A8 WO2005002591 A8 WO 2005002591A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cephalin
- lecithin
- lipositol
- impetigo
- tinea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EG2003070632 | 2003-07-02 | ||
EG2003070632 | 2003-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005002591A1 WO2005002591A1 (en) | 2005-01-13 |
WO2005002591A8 true WO2005002591A8 (en) | 2005-04-07 |
Family
ID=33560713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EG2004/000008 WO2005002591A1 (en) | 2003-07-02 | 2004-02-25 | Treatment psoriasis, impetigo, tinea by lipositol, cephalin and lecithin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005002591A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2884425B3 (en) * | 2005-04-18 | 2007-05-25 | Paul Robert Francois Dupont | PHARMACEUTICAL COMPOSITION FOR TREATING PSORIASIS |
CA2606255C (en) | 2005-04-18 | 2013-10-08 | Sc Dicophar | Use of lecithin as a medicament for treating psoriasis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3829899C2 (en) * | 1988-09-02 | 1994-12-15 | Reutter Werner | Glycerine glycophosphatides and pharmaceutical compositions containing them for combating skin diseases |
US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
AU2550397A (en) * | 1997-03-25 | 1998-10-20 | Wilson Trafton Crandall | Topical moisturizing composition and method |
AU5449699A (en) * | 1999-09-07 | 2001-04-10 | Kabushiki Kaisha Soken | Skin normalizing agents |
-
2004
- 2004-02-25 WO PCT/EG2004/000008 patent/WO2005002591A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005002591A1 (en) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG150563A1 (en) | Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same | |
Dembitsky et al. | Lipid compounds of freshwater sponges: family Spongillidae, class Demospongiae | |
AR021481A1 (en) | COMPOUNDS OF 1,2,3,4-TETRAHYDROQUINOLINS 2-SUBSTITUTED 4-CARBOXYAMIN REPLACED, USE FOR THE PREPARATION OF MEDICINES, COMPOSITIONS AND KIT CONTAINING IT | |
WO2003013497A1 (en) | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction | |
Carballeira et al. | Novel very long-chain α-methoxylated Δ5, 9 fatty acids from the sponge Asteropus niger are effective inhibitors of topoisomerases IB | |
KR20120009995A (en) | Mixed micells improving stability of retinyl palmitates, preparation method thereof and cosmetic compositions containing the same | |
Yurkova | Free-radical reactions of glycerolipids and sphingolipids | |
JP3100783B2 (en) | Phosphatidylcholine and method for producing the same | |
WO2005002591A8 (en) | Treatment psoriasis, impetigo, tinea by lipositol, cephalin and lecithin | |
Lee et al. | Individual phosphatidylcholine species analysis by RP-HPLC-ELSD for determination of polyenylphosphatidylcholine in lecithins | |
JP2018522876A (en) | Multiphase composition | |
Noble et al. | Metabolism of the yolk phospholipids by the developing chick embryo | |
WO2012109151A1 (en) | Permeation enhancers with liposomes for topical formulations | |
EP2158915B1 (en) | Acylglycerophospholipides for treating symptoms accompanying cancer | |
Niezgoda et al. | Phosphatidylcholine with cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers: synthesis and cytotoxic studies | |
Fong et al. | Studies on the hydrogen belts of membranes: I. Diester, diether, and dialkyl phosphatidylcholines and polyoxyethylene glycerides in monolayers with cholesterol | |
Kobayashi et al. | Comparative study of the product components of lipid oxidation in aqueous and organic systems | |
Malhotra et al. | The distribution and lipid composition of ultracentrifugally separated lipoproteins of young and old rat plasma | |
Huang et al. | Oxygenation of arachidonoyl lysophospholipids by lipoxygenases from soybean, porcine leukocyte, or rabbit reticulocyte | |
Hosokawa et al. | Synergistic Effects of Highly Unsaturated Fatty Acid‐containing Phosphatidyl‐ethanolamine on Differentiation of Human Leukemia HL‐60 Cells by Dibutyryl Cyclic Adenosine Monophosphate | |
NAITO et al. | Lipids of Human Promyclocytic Leukemia Cell HL-60: Increasing Levels of Ether-Linked Phospholipids during Retinoic Acid-Induced Differentiation | |
US11617710B2 (en) | Self-emulsifying bioactive concentrates | |
Shishkina et al. | Functioning similarity of the physicochemical regulatory system of the lipid peroxidation in the membrane and organ levels | |
JP2514995B2 (en) | Composition for promoting absorption of substance by transdermal and transmucosal | |
US20050158835A1 (en) | Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 02/2005 UNDER (71,72) THE ADDRESS SHOULD READ "ABO RADY AREA AL MAHALLA ALKOBRA CITY(EG)" |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |